| Particulars |
|
|
|
|
Company Name
| Glaxosmithkline Pharmaceuticals Ltd
|
Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
169.41 |
B.V. (₹) |
115.10 |
| Sales(₹ Cr.) |
3,723.49 |
NP (₹ Cr.) |
865.43 |
| NP Var% |
33.00 |
Div% |
540.00 |
| CPS(₹) |
55.00 |
EPS (₹) |
51.10 |
| Traded Value(₹ Lakhs) |
206.85 |
52 Week High |
3,516.00 |
| 52 Week Low |
1,924.00 |
Price BSE |
2,773.00 |
| Price NSE |
2,777.00 |
Market Capital (₹ Cr.) |
46,983.07 |
| P/C Ratio |
50.40 |
P/E Ratio |
54.30 |
| Price Vs.BV |
24.09 |
|
| Latest Quarter |
| Year End |
202506 |
Sales (₹ Cr.) |
804.83 |
| NP(₹ Cr.) |
204.70 |
NP Var % |
13.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
3,526.90 |
| OPM |
24.19 |
NP |
795.84 |
| NP Var% |
22.55 |
EPS |
55.42 |
| PE |
50.04 |
|
|